☆ 4.6 Letter

Rosuvastatin as a novel treatment of non-alcoholic fatty liver disease in hyperlipidemic patients

ATHEROSCLEROSIS (2006)

Journal

ATHEROSCLEROSIS

Volume 184, Issue 1, Pages 233-234

Publisher

ELSEVIER IRELAND LTD

DOI: 10.1016/j.atherosclerosis.2005.08.021

Keywords

rosuvastatin; fatty liver disease; steatosis; anticholesteremic agents

Categories

Cardiac & Cardiovascular Systems Peripheral Vascular Disease

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper

Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6

Not enough ratings

Secondary Ratings

Novelty

-

Significance

-

Scientific rigor

-

Rate this paper

Recommended

No Data Available

No Data Available

No Data Available

© Peeref 2019-2024. All rights reserved.